{ "docId": "019dd923-622c-750b-8b9a-40e2965928db", "docSlug": "e5bffbaac707", "documentTitle": "TransMedics (TMDX)", "authorId": "58_Scorpion_Capital", "authorName": "Scorpion Capital", "documentKindSlug": "research-note", "documentKindLabel": "Research note", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2025-01-10 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 147, "pageCount": 342, "prevPage": 146, "nextPage": 148, "slideType": "expose_contradiction", "function": "expose_contradiction", "density": "dense", "nDataPoints": 0, "notes": "The slide uses a combination of summary text and a direct quote from a high-volume user to substantiate the claim of unethical organ allocation practices.", "elementsJson": [ "paragraph", "quote_block", "footnote" ], "metadataConfidence": 0.95, "imagePath": null, "slideHref": "/slides/019dd923-622c-750b-8b9a-40e2965928db/147", "deckHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db", "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db.json", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db#slide-147", "components": [ { "bbox": { "h": 0.03, "w": 0.86, "x": 0.07, "y": 0.55 }, "kind": "callout", "text": "Open secret among high volume TransMedics users that the organ allocation process is bypassed", "attrs": null, "subkind": "primary", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "4933eec1-e063-4793-8b60-9abb613f80aa", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.25, "w": 0.86, "x": 0.07, "y": 0.23 }, "kind": "paragraph", "text": "A transplant chief described a large meeting held by Transmedics – “the leaders of many transplant programs were invited…I was one of them” – where the problem of hijacking the OPTN list was acknowledged – but behind closed doors. We emphasize that this surgeon appears to benefit from the scheme: “calling TransMedics experienced users and saying…’would you be interested?’…[redacted] got up to the podium at that meeting and said…do it under OPTN guidelines, do not bypass the list…the OPO where that liver was procured should be the one to go down the central list…it should not be TransMedics calling UCSD, another super-user, and saying, hey [surgeon name redacted], would have you have a patient….”", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "009a4a30-0e8f-48a2-9de5-1ca7c50fd09c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.35, "w": 0.86, "x": 0.07, "y": 0.58 }, "kind": "quote", "text": "“TransMedics held this in-person meeting in Boston right before the American College of Surgeons last year. The leaders of many transplant programs were invited; I was one of them…and at that meeting, this very issue was discussed, this concept of bypassing the list…so, a center that is not normally accustomed to using the liver on pump, they’re not going to take a liver like that. And time is important to figure out who you would use the graft for…calling TransMedics experienced users and saying, the primary center we procured for no longer wants to use this graft. Would you be interested?” So, [redacted] got up to the podium at that meeting and said, I understand why you are doing this…make sure that you do it under OPTN guidelines, do not bypass the list. And everybody in the room was in agreement…I get the practice that they’re talking about. What should happen, for example, the liver I just told you about where we decided not to use it, what should happen is the OPO where that liver was procured should be the one to go down the central list and say the next patient on the list is a patient from [redacted]. Let’s call [redacted] and explain the situation and see if they are willing to use. It should not be TransMedics calling [redacted], another super-user, and saying, hey [surgeon name redacted], would you have a patient on your list? The OPO should be the one to say the next patient on the list is from [redacted], and then reach out to the surgeon and say your patient is next on the list. Would you be willing to use this liver?” – Transplant surgeon; high volume user", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "b81331bc-1830-45e1-9286-b3646fba5b70", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "“TransMedics held this in-person meeting in Boston right before the American College of Surgeons last year. The leaders of many transplant programs were invited; I was one of them...and at that meeting, this very issue was discussed, this concept of bypassing the list...so, a center that is not normally accustomed to using the liver on pump, they’re not going to take a liver like that. And time is important to figure out who you would use the graft for...calling TransMedics experienced users and saying, the primary center we procured for no longer wants to use this graft. Would you be interested?” So, [redacted] got up on the podium at that meeting and said, I understand why you are doing this...make sure that you do it under OPTN guidelines, do not bypass the list. And everybody in the room was in agreement...I get the practice that they’re talking about. What should happen, for example, the liver I just told you about where we decided not to use it, what should happen is the OPO where that liver was procured should be the one to go down the central list and say the next patient on the list is a patient from [redacted]. Let’s call [redacted] and explain the situation and see if they are willing to use. It should not be TransMedics calling [redacted], another super-user, and saying, hey [surgeon name redacted], would you have a patient on your list? The OPO should be the one to say the next patient on the list is from [redacted], and then reach out to the surgeon and say your patient is next on the list. Would you be willing to use this liver?” — Transplant surgeon; high volume user", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd953-5373-719d-a97d-83e0a1f97378", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.3, "x": 0.07, "y": 0.95 }, "kind": "source-note", "text": "Source: Scorpion Capital consultation calls with experts", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "aeeba83d-20c1-4a8e-b08c-ff905844ef46", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.86, "x": 0.07, "y": 0.07 }, "kind": "title", "text": "Multiple TransMedics “super users” indicated that the company bypasses OPTN rules to allegedly take over the organ allocation process from OPO’s in order to preferentially offer them organs – already on the device, naturally.", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "62977ddd-88e5-49e8-a530-749f8e56796a", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [ { "name": "fraud-exposure", "slug": null, "matchId": "d7725ef3-8a1c-41e7-a1ab-df814fbc8957", "evidence": "The slide explicitly details an alleged scheme to bypass regulatory (OPTN) guidelines for commercial gain.", "confidence": 0.9 } ], "arcBeats": [], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }